Eisenhofer G, Esler M D, Cox H S, Meredith I T, Jennings G L, Brush J E, Goldstein D S
Baker Medical Research Institute, Prahran, Victoria, Australia.
J Clin Endocrinol Metab. 1990 Jun;70(6):1710-20. doi: 10.1210/jcem-70-6-1710.
Neuronal uptake is an important mechanism for the removal of norepinephrine, but its contribution to the removal of epinephrine is unknown. This study compared the neuronal removal of circulating epinephrine and norepinephrine by examination of the cardiac extractions or plasma clearances of [3H]norepinephrine and endogenous or 3H-labeled epinephrine in healthy subjects, patients with cardiovascular disorders, and subjects administered desipramine to block neuronal uptake. In rabbits the plasma clearances of [3H]epinephrine and [3H] norepinephrine by neuronal uptake and the formation of dihydroxyphenylglycol (DHPG) from simultaneously infused [3H] norepinephrine and epinephrine were compared. In normal patients 51 +/- 3% of plasma epinephrine was extracted during one pass through the coronary circulation, significantly less than the cardiac extraction of [3H]norepinephrine (78 +/- 1%). In patients with cardiovascular disorders extractions of epinephrine (34 +/- 3%) remained lower than those of [3H]norepinephrine (63 +/- 2%). After desipramine, cardiac extraction of epinephrine was reduced to 12 +/- 2% and [3H]norepinephrine to 20 +/- 3%. In subjects infused simultaneously with [3H]epinephrine and [3H] norepinephrine, desipramine reduced the cardiac extraction of [3H]epinephrine by 28 +/- 6%, significantly less than the 49 +/- 7% reduction in [3H]epinephrine extraction; the plasma clearance of [3H]epinephrine was reduced by 4 +/- 5%, significantly less than the 20 +/- 6% reduction in [3H]norepinephrine clearance. In rabbits desipramine reduced the plasma clearance of [3H] epinephrine by 18%, significantly less than the 42% reduction in [3H]norepinephrine clearance; production of DHPG from epinephrine was less than half the production of [3H]DHPG from [3H]norepinephrine. The above differences indicated that epinephrine was removed 44-64% less avidly than norepinephrine by uptake into and metabolism within sympathetic neurons.
神经元摄取是去甲肾上腺素清除的重要机制,但其对肾上腺素清除的作用尚不清楚。本研究通过检测健康受试者、心血管疾病患者以及服用地昔帕明以阻断神经元摄取的受试者中[3H]去甲肾上腺素和内源性或3H标记的肾上腺素的心脏摄取或血浆清除率,比较了循环中肾上腺素和去甲肾上腺素的神经元清除情况。在兔中,比较了通过神经元摄取的[3H]肾上腺素和[3H]去甲肾上腺素的血浆清除率,以及同时注入的[3H]去甲肾上腺素和肾上腺素生成二羟基苯乙二醇(DHPG)的情况。在正常患者中,一次通过冠脉循环期间,51±3%的血浆肾上腺素被摄取,显著低于[3H]去甲肾上腺素的心脏摄取率(78±1%)。在心血管疾病患者中,肾上腺素的摄取率(34±3%)仍低于[3H]去甲肾上腺素的摄取率(63±2%)。服用地昔帕明后,肾上腺素的心脏摄取率降至12±2%,[3H]去甲肾上腺素降至20±3%。在同时注入[3H]肾上腺素和[3H]去甲肾上腺素的受试者中,地昔帕明使[3H]肾上腺素的心脏摄取率降低28±6%,显著低于[3H]肾上腺素摄取率降低的49±7%;[3H]肾上腺素的血浆清除率降低4±5%,显著低于[3H]去甲肾上腺素清除率降低的20±6%。在兔中,地昔帕明使[3H]肾上腺素的血浆清除率降低18%,显著低于[3H]去甲肾上腺素清除率降低的42%;肾上腺素生成DHPG的量不到[3H]去甲肾上腺素生成[3H]DHPG量的一半。上述差异表明,通过交感神经元摄取和代谢,肾上腺素的清除比去甲肾上腺素低44 - 64%。